Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Skolnick, Phil
294  Ergebnisse:
Personensuche X
?
1

Reversal of Opioid‐Induced Respiratory Depression in Health..:

Ellison, Mark ; Hutton, Emily ; Webster, Lynn.
The Journal of Clinical Pharmacology.  64 (2024)  7 - p. 828-839 , 2024
Link: https://doi.org/10.1002/..
 
?
2

Comment on: Can Intranasal Nalmefene Reduce the Number of O..:

Skolnick, Phil
Clinical Pharmacology in Drug Development.  13 (2024)  3 - p. 317-318 , 2024
Link: https://doi.org/10.1002/..
 
?
3

Editorial: Discovery, development and implementation of imp..:

Heidbreder, Christian ; Greenwald, Mark K. ; Le Foll, Bernard.
Frontiers in Psychiatry.  15 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
4

Comparison of intranasal naloxone and intranasal nalmefene ..:

Laffont, Celine M. ; Purohit, Prasad ; Delcamp, Nash..
Frontiers in Psychiatry.  15 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
5

Pharmacokinetic Properties of an FDA‐approved Intranasal Na..:

Crystal, Roger ; Ellison, Mark ; Purdon, Charlotte.
Clinical Pharmacology in Drug Development.  13 (2023)  1 - p. 58-69 , 2023
Link: https://doi.org/10.1002/..
 
?
6

Treatment of overdose in the synthetic opioid era:

Skolnick, Phil
Pharmacology & Therapeutics.  233 (2022)  - p. 108019 , 2022
Link: https://doi.org/10.1016/..
 
?
7

Countermeasures for Preventing and Treating Opioid Overdose:

France, Charles P. ; Ahern, Gerard P. ; Averick, Saadyah...
Clinical Pharmacology & Therapeutics.  109 (2020)  3 - p. 578-590 , 2020
Link: https://doi.org/10.1002/..
 
?
8

Enhanced Intranasal Absorption of Naltrexone by Dodecyl Mal..:

Krieter, Philip ; Gyaw, Shwe ; Chiang, C. Nora..
The Journal of Clinical Pharmacology.  59 (2019)  7 - p. 947-957 , 2019
Link: https://doi.org/10.1002/..
 
?
9

Cannabinoid1 (CB-1) receptor antagonists: a molecular appro..:

Skolnick, Phil ; Crystal, Roger
Journal of Neural Transmission.  127 (2019)  2 - p. 279-286 , 2019
Link: https://doi.org/10.1007/..
 
?
10

Be positive about negatives–recommendations for the publica..:

Bespalov, Anton ; Steckler, Thomas ; Skolnick, Phil
European Neuropsychopharmacology.  29 (2019)  12 - p. 1312-1320 , 2019
Link: https://doi.org/10.1016/..
 
?
11

On the front lines of the opioid epidemic: Rescue by naloxo..:

Skolnick, Phil
European Journal of Pharmacology.  835 (2018)  - p. 147-153 , 2018
Link: https://doi.org/10.1016/..
 
?
12

The development of glutamate-based antidepressants is takin..:

Garay, Ricardo ; Zarate Jr., Carlos A. ; Cavero, Icilio...
Drug Discovery Today.  23 (2018)  10 - p. 1689-1692 , 2018
Link: https://doi.org/10.1016/..
 
?
13

One Good Decision: The Policy Argument for Extended Release..:

Koppel, Stephen ; Skolnick, Phil
Journal of Drug Policy Analysis.  10 (2017)  1 - p. , 2017
Link: https://doi.org/10.1515/..
 
?
14

Measures of outcome for stimulant trials: ACTTION recommend..:

Kiluk, Brian D. ; Carroll, Kathleen M. ; Duhig, Amy...
Drug and Alcohol Dependence.  158 (2016)  - p. 1-7 , 2016
Link: https://doi.org/10.1016/..
 
?
15

Re-energizing the Development of Pain Therapeutics in Light..:

Skolnick, Phil ; Volkow, Nora D.
Neuron.  92 (2016)  2 - p. 294-297 , 2016
Link: https://doi.org/10.1016/..
 
1-15